COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach
- 23 May 2020
- journal article
- editorial
- Published by Elsevier BV in Progress in Pediatric Cardiology
- Vol. 57, 101232
- https://doi.org/10.1016/j.ppedcard.2020.101232
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19Journal of Infection, 2020
- Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort studyThe Lancet Infectious Diseases, 2020
- The Rheumatologist’s Role in COVID-19The Journal of Rheumatology, 2020
- Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in childrenIntensive Care Medicine, 2020
- Therapeutic Plasma Exchange in Children With Thrombocytopenia-Associated Multiple Organ Failure: The Thrombocytopenia-Associated Multiple Organ Failure Network Prospective ExperienceCritical Care Medicine, 2018
- Clinical Manifestations of Kawasaki Disease Shock SyndromeClinical Pediatrics, 2017
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children*Pediatric Critical Care Medicine, 2014
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012